Comparison Chart Alzamend Neuro, Inc.

Stocks

ALZN

US02262M6057

Biotechnology & Medical Research

Delayed Nasdaq 15:42:50 2026-09-16 EDT			5-day change	1st Jan Change
1.835 ^USD	+3.09%		+9.23%	+0.82%

09-10	Alzamend Neuro, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026	CI
08-20	Alzamend Neuro Reports Resting-State Fmri Findings For Al001 Accepted For Poster Presentation At Neuroscience 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ALZAMEND NEURO, INC.	Other Biotechnology & Medical Research	+3.09%	+9.23%	+0.82%	-29.96%	-99.95%	8.53M